UK Health Secretary Wes Streeting has announced plans to set up a new COVID-19 vaccine compensation program for those ‘left disabled’ after being jabbed after the current one broke down under the pressure of the sheer amount of claimants.
The existing scheme, the Vaccine Damage Payment Scheme (VDPS), could not handle the high volume of claims, which saw millions flood the system following the 2021 jab rollout.
Vaxx-injured applicants have been awarded compensation for conditions including dangerous blood clots, excessive swelling of the vaccinated limb, strokes, heart attacks, and facial paralysis, to name a few.
According to Freedom of Information requests by the Telegraph, 97 Percent of successful claims came from those who received the AstraZeneca, Pfizer, and Moderna vaccines.
However, those injured by the vaccine argue the payment does not go far enough, claiming that brain injuries have left them unable to work and pay for ongoing care costs for the rest of their lives.
Sir Jeremy Wright MP, the shadow attorney general, said:
“If you are in the very small minority of those injured [by the Covid vaccine], those people have a right to expect the state to look after them properly – they were only doing what the state asked them to do.”
Some patients suffered from dangerous rare blood clotting complications triggered by the AstraZeneca jab
Astoundingly, the scheme says that those injured by a vaccine must either be killed or be at least 60 percent disabled by their injury in order to get compensation.
Meanwhile, Astrazeneca is being sued in a class action lawsuit over claims caused death and serious injury in dozens of cases.
RELATED: Florida Woman, 23, Left Blind After Being Forced to Take 3 Vaccine injections
But the Government has indemnified AstraZeneca against any legal action, leaving those whose lives were ruined by the jab and families reeling from the death of loved ones left to fend for themselves.
The AstraZeneca jab was discovered to carry a very rare risk of triggering potentially fatal blood clots but was somehow “missed” in clinical trials, resulting a tsunami of deaths.
The Daily Mail reports:
“This side effect missed in clinical trials, because of how rare it was, is called thrombosis with thrombocytopenia syndrome (TTS), or alternatively vaccine-induced immune thrombotic thrombocytopenia (VITT). Cambridge-based AstraZeneca, which is contesting the legal claims, acknowledged in a legal document submitted to the High Court in February that its vaccine ‘can, in very rare cases, cause TTS’.”
The firm responded to concerns, saying, “Our sympathy goes out to anyone who has lost loved ones or reported health problems.”
“Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines.
“From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.”
RELATED: Top Pathologist Warns Vaxxed Are ‘Dropping Like Flies’ as Turbo Cancers Increase by 55%
